Pharming N.V.(US:PHAR) Globenewswire·2026-02-17 07:00Core Viewpoint - Pharming Group N.V. will participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference, scheduled for February 25-26, 2026, highlighting its commitment to engaging with investors and stakeholders in the biopharmaceutical sector [1][2]. Company Overview - Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative medicines for patients with rare, debilitating, and life-threatening diseases [3]. - The company is headquartered in Leiden, the Netherlands, with a significant number of employees based in the U.S. [3]. Event Details - Fabrice Chouraqui, CEO, and Anurag Relan, M.D., CMO, will present on February 25 at 12:40 PM ET / 6:40 PM CET, with a live webcast available on Pharming's website [2]. - Investors can schedule one-on-one meetings with Pharming's management team through Investor Relations [2].